The Yosemade Medicine Research Institute serves as the research and development center of Apeloa. Yosemade can be divided into three major branches. The main institute located the Hangzhou Biopharma Town focuses on formulation study and clinical research. The Hengdian branch concentrates on the research of API while the Chendu branch centers on special formulations. Yosemade has over 10,000 m2 of facilities in total.
At Yosemade, we strive for our vision – Innovation makes life happier. We make the needs of patients the top priority and provide advanced clinical products and services. We build our core competitiveness on research and development and the culture of Learning, Innovation, Cooperation, and Effectiveness.
Currently there are over 30 active projects at Yosemade, covering the medications of oncology, infectious disease, and cardiology. The research at Yosemade is always driven by independent innovations, which is aligned with Apeloa’s main strategy of “expert in API, excellent in formulation, and strong in CDMO”.
Apeloa aims to build an R&D system of both generic and patent drugs, to form a complete system of pharmaceutical study, pre-clinical study, and registration. In addition, efficient platforms are established for patent drugs, high value generics, and traditional Chinese prescriptions.